Effects of Ω-3 (n-3) Fatty Acid Supplementation on Insulin Sensitivity in Horses

The objective of this study was to examine the effects of dietary ω-3 fatty acid supplementation on insulin sensitivity (SI) in horses. Twenty-one mares were blocked by age, body weight (BW), and body condition score (BCS) and randomly assigned to one of three dietary treatments. Treatments consisted of (1) 38 g of n-3 fatty acids via fish and algae supplement and diet (MARINE), (2) 38 g of n-3 fatty acids via a flaxseed meal from the supplement and diet (FLAX), and (3) control (CON) no supplemental fatty acid. Treatments were supplemented for 90 days. Frequent sampling intravenous glucose tolerance tests were performed on days 0, 30, 60, and 90. Blood samples were analyzed for glucose and insulin. The minimal model was applied for the glucose and insulin curves using MinMod Millennium. SI increased 39% (P < .007) across all treatment groups. Acute insulin response to glucose decreased 22% (P < .006) between days 30 and 60 and increased (P = .040) again at day 90. Disposition index (combined SI and β pancreatic response) increased (P = .03) by 53% in the MARINE- and 48% in the FLAX-supplemented horses and did not change with time in the CON group. In insulin-resistant mares, MARINE- and FLAX-treated horses had an increase in SI (P = .09). It would be interesting to test this supplement in a larger group of insulin-resistant horses. If proven effective, supplementation with ω-3 fatty acids would help to reduce problems associated with insulin resistance in horses.     

Evaluation of twice-daily, low-dose trilostane treatment administered orally in dogs with naturally occurring hyperadrenocorticism

OBJECTIVE: To evaluate the effects of twice-daily oral administration of a low-dose of trilostane treatment and assess the duration of effects after once-daily trilostane administration in dogs with naturally occurring hyperadrenocorticism (NOH). DESIGN: Prospective study. ANIMALS: 28 dogs with NOH. PROCEDURES: 22 dogs received 0.5 to 2.5 mg of trilostane/kg (0.23 to 1.14 mg/lb) orally every 12 hours initially. At intervals, dogs were reevaluated; owner assessment of treatment response was recorded. To assess drug effect duration, 16 of the 22 dogs and 6 additional dogs underwent 2 ACTH stimulation tests 3 to 4 hours and 8 to 9 hours after once-daily trilostane administration. RESULTS: After 1 to 2 weeks, mean trilostane dosage was 1.4 mg/kg (0.64 mg/lb) every 12 hours (n = 22 dogs; good response [resolution of signs], 8; poor response, 14). Four to 8 weeks later, mean dosage was 1.8 mg/kg (0.82 mg/lb) every 12 or 8 hours (n = 21 and 1 dogs, respectively; good response, 15; poor response, 5; 2 dogs were ill). Eight to 16 weeks after the second reevaluation, remaining dogs had good responses (mean dosages, 1.9 mg/kg [0.86 mg/lb], q 12 h [n = 13 dogs] and 1.3 mg/kg [0.59 mg/lb], q 8 h [3]). At 3 to 4 hours and 8 to 9 hours after once-daily dosing, mean post-ACTH stimulation serum cortisol concentrations were 2.60 and 8.09 Pg/dL, respectively. CONCLUSIONS AND CLINICAL RELEVANCE: In dogs with NOH, administration of trilostane at low doses every 12 hours was effective, although 2 dogs became ill during treatment. Drug effects diminished within 8 to 9 hours. Because of potential adverse effects, lower doses should be evaluated.     

Clinical, echocardiographic, and electrocardiographic abnormalities in Boxers with cardiomyopathy and left ventricular systolic dysfunction: 48 cases (1985-2003)

OBJECTIVE: To identify clinical, echocardiographic, and electrocardiographic abnormalities in Boxers with cardiomyopathy and echocardiographic evidence of left ventricular systolic dysfunction. DESIGN: Retrospective study. ANIMALS: 48 mature Boxers. PROCEDURE: Medical records were reviewed for information on age; sex; physical examination findings; and results of electrocardiography, 24-hour ambulatory electrocardiography, thoracic radiography, and echocardiography. RESULTS: Mean age of the dogs was 6 years (range, 1 to 11 years).Twenty (42%) dogs had a systolic murmur, and 9 (19%) had ascites. Congestive heart failure was diagnosed in 24 (50%) dogs. Seventeen (35%) dogs had a history of syncope. Mean fractional shortening was 14.4% (range, 1% to 23%). Mean left ventricular systolic and diastolic diameters were 4.5 cm (range, 3 to 6.3 cm) and 5.3 cm (range, 3.9 to 7.4 cm), respectively. Twenty-eight (58%) dogs had a sinus rhythm with ventricular premature complexes (VPCs), and 20 had supraventricular arrhythmias (15 with atrial fibrillation and 5 with sinus rhythm and atrial premature complexes). Sixteen of the dogs with supraventricular arrhythmias also had occasional VPCs. Morphology of the VPCs seen on lead II ECGs was consistent with left bundle branch block in 25 dogs, right bundle branch block in 8, and both in 11. CONCLUSIONS AND CLINICAL RELEVANCE: Results suggest that Boxers with cardiomyopathy and left ventricular dysfunction frequently have arrhythmias of supraventricular or ventricular origin. Whether ventricular dysfunction was preceded by electrical disturbances could not be determined from these data, and the natural history of myocardial disease in Boxers requires further study.     

Pretanned leather shavings in a supplement mixture for steers: II. Digesta kinetics, ruminal fermentation, and grazing behavior in steers grazing dormant wheatgrass pasture

Twelve ruminally cannulated steers (Angus x Holstein; average initial BW = 533 +/- 3.28 kg) were randomly allotted to one of three treatments (four steers/treatment) to evaluate the use of pretanned leather shavings as a component of a protein supplement for steers grazing dormant intermediate wheatgrass (Thinopyrum intermedium Host). Steers were allotted to one of three treatments: 1) no supplement (control); 2) supplementation intraruminally at 0700 with soybean meal at .2% of BW (as-fed basis); 3) supplementation intraruminally with soybean meal and pretanned leather shavings (17:8 ratio, respectively) at .16% of BW (as-fed basis). Supplements were formulated so that intakes were isonitrogenous and were placed intraruminally once daily (0700). Sampling periods were conducted February 3 to 16 and February 17 to March 5, 1995. In situ organic matter disappearance of the soybean meal supplement was greater (P > .05) than that of the leather shavings supplement at all incubation times (1, 3, 6, 9, 12, 24, and 48 h). Data suggested that pretanned leather shavings within the leather shavings supplement were only 25% degradable within the rumen. Forage OM intake (control = 12.7, soybean meal = 12.7, and leather shavings = 13.4 g/kg of BW), grazing time, and grazing efficiency were not altered (P > .10) by supplementation or type of supplement provided but did increase between the February and March samplings. Total intake was increased (P = .09) with supplementation and reflected the addition of the protein supplements. Particulate and fluid passage estimates were unaffected (P > .10) by the supplements; however, gastrointestinal fill increased (P = .01) between the February and March samplings. Ruminal pH was lower (P = .04) and ruminal NH3 N concentration was greater (P = .02) for supplemented steers than for control steers, and supplementation treatments did not differ (P > .10). Total VFA concentrations were increased (P = .01) by supplementation but were not affected by type of supplement provided (P > .10). Ruminal molar proportions of acetate and propionate and the ratio of these two VFA did not differ (P > .10) between supplementation types. Nonetheless, supplementation increased molar proportions of butyrate (P = .04), valerate (P = .02), and isovalerate (P = .05), and leather shavings supplementation increased (P = .10) isobutyrate proportions over those in steers supplemented with soybean meal. Combining pretanned leather shavings with soybean meal seemed to have no deleterious effects on forage intake, digesta passage, grazing behavior, or ruminal fermentation and seemed to provide effects similar to those of soybean meal alone.     

Bordetella bronchiseptica-reactive antibodies in Canadian polar bears

Bordetella bronchiseptica is a promiscuous bacterium that infects a variety of species but has not been reported in free-ranging polar bears (Ursus maritimus). Sera from 385 polar bears from the western Hudson Bay region, 1986 to 2017, were tested for reactivity to B. bronchiseptica with enzyme-linked immunosorbent assays using anti-canine IgG and Streptococcus protein G as secondary reagents. Sera from bears had variable reactivity to B. bronchiseptica antigens, and there was no difference among bears that had a history of coming near the town of Churchill, Manitoba, and bears that did not. Although the sources of exposure were not determined, equivalent results in both groups suggest that potential exposure to humans (aside from handling during sampling) and their animals (dogs) was not an important co-factor in sero-positivity to B. bronchiseptica.